| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/1999 | WO1999017709A2 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | WO1999017616A1 Structure-based rational design of compounds to inhibit papillomavirus infection |
| 04/15/1999 | WO1999017610A1 Protein delivery by secretory gland expression |
| 04/15/1999 | WO1999017607A2 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999011778B1 Antisense treatment of pulmonary hypertension |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999008668A3 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 04/15/1999 | WO1999007854A3 Serine/threonine kinase, and uses related thereto |
| 04/15/1999 | WO1999007849A3 Human reticulocalbin isoforms |
| 04/15/1999 | WO1999007324A3 Conjugates targeted to the interleukin-2 receptor |
| 04/15/1999 | WO1999006440A8 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 04/15/1999 | WO1999005502A3 Modulation of multicellular aggregates by solid stress |
| 04/15/1999 | WO1999005300A3 Ghrh expression system and methods of use |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 04/15/1999 | WO1999002153A9 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases |
| 04/15/1999 | WO1999000422A9 Novel family of pheromone receptors |
| 04/15/1999 | WO1999000412A9 Interferon stimulating protein and uses thereof |
| 04/15/1999 | WO1999000409A9 Chemically modified a-macroglobulins, methods of making, and methods of using the same in anti-cytokine therapy |
| 04/15/1999 | WO1999000408A3 Human transmembrane protein from the transmembrane 4 superfamily |
| 04/15/1999 | WO1998049190A9 Substituted oxadiazole cysteine protease inhibitors |
| 04/15/1999 | WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/15/1999 | WO1998047531A3 Fc receptor non-binding anti-cd3 monoclonal antibodies deliver a partial tcr signal and induce clonal anergy |
| 04/15/1999 | WO1998046645A3 Method for the production of antihuman antigen receptors and uses thereof |
| 04/15/1999 | WO1998045429A3 Polypeptides involved in the staurosporine induced apoptotic pathway |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | WO1998043993A3 Nucleic acid catalysts |
| 04/15/1999 | DE4447664C2 Recombinant papilloma virus-like particles contg. L1 or L2 proteins |
| 04/15/1999 | DE19811047C1 Copper-containing ribonucleoproteins |
| 04/15/1999 | DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives |
| 04/15/1999 | DE19744676A1 Combination product for cancer therapy |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2309554A1 Mammalian-derived peptides for the treatment of microbial infection |
| 04/15/1999 | CA2308126A1 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2305786A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 04/15/1999 | CA2305712A1 Natural humanized antibody |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305708A1 A keratinocyte derived protease |
| 04/15/1999 | CA2305707A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit |
| 04/15/1999 | CA2305689A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | CA2305688A1 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305682A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | CA2305620A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | CA2305528A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | CA2305182A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | CA2304803A1 Protein delivery by secretory gland expression |
| 04/15/1999 | CA2304796A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304116A1 Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 04/15/1999 | CA2273186A1 Structure-based rational design of compounds to inhibit papillomavirus infection |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908518A2 MurE gene encoding uridine-diphosphate-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase of Streptococcus pneumoniae |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908516A1 ABC transporter |
| 04/14/1999 | EP0908515A2 Pancreatic polypeptide |
| 04/14/1999 | EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae |
| 04/14/1999 | EP0908105A1 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof |
| 04/14/1999 | EP0907742A2 Cyclic nucleotide phosphodiesterase |
| 04/14/1999 | EP0907739A1 Porcine retrovirus |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907737A1 Il-6 mutein |
| 04/14/1999 | EP0907736A2 Cc-type chemokines |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907733A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907731A1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses |
| 04/14/1999 | EP0907730A1 Haemopoietin receptor and genetic sequences encoding same |
| 04/14/1999 | EP0907729A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
| 04/14/1999 | EP0907724A2 Von willebrand factor multimerase |
| 04/14/1999 | EP0907720A1 Combined radiotherapy and immunotherapy to treat cancer |
| 04/14/1999 | EP0907719A1 Human cytokine polypeptide |
| 04/14/1999 | EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS |
| 04/14/1999 | EP0907659A1 Synthetic inhibitors of hepatitis c virus ns3 protease |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907378A1 Concentrated antibody preparation |
| 04/14/1999 | EP0907377A1 Novel compounds |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907374A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 04/14/1999 | EP0907373A1 Use of il-12 and ifn-alpha for the treatment of infectious diseases |
| 04/14/1999 | EP0907372A1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
| 04/14/1999 | EP0907371A1 A synthetic peptide and its uses |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907369A1 Materials and methods for treatment of plaquing diseases |
| 04/14/1999 | EP0907368A1 Novel heparin binding peptides |
| 04/14/1999 | EP0907366A1 Combination therapy for treatment of erectile dysfunction |
| 04/14/1999 | EP0907349A1 Compositions for the removal of dental plaque |
| 04/14/1999 | EP0907337A1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation |
| 04/14/1999 | EP0821694A4 Conotoxin peptides |
| 04/14/1999 | EP0794782A4 Cobalt schiff base compounds |
| 04/14/1999 | EP0777685B1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 04/14/1999 | EP0759940A4 A dna molecule encoding a mast cell function-associated antigen (mafa) |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0734436B1 Inhibition of dna methyltransferase |
| 04/14/1999 | EP0679659B1 Cathepsin-l-specific inhibitor polypeptide |
| 04/14/1999 | EP0669938B1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION |